Back
Sartorius Stedim Biotech SA 10K Form
Sell
48
SRTOY
Sartorius Stedim Biotech SA
Last Price:
20.40
Seasonality Move:
4.42%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SRTOY News And Ratings
See the #1 stock for the next 7 days that we like better than SRTOY
SRTOY Financial Statistics
Sales & Book Value
| Annual Sales: | $3B |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.48 |
| Price / Book: | 4.33 |
Profitability
| EPS (TTM): | 0.15930 |
|---|---|
| Net Income (TTM): | $150.24M |
| Gross Margin: | $1.34B |
| Return on Equity: | 4.38% |
| Return on Assets: | 1.87% |
Sartorius Stedim Biotech SA Earnings Forecast
Key Sartorius Stedim Biotech SA Financial Ratios
- The Gross Profit Margin over the past 19 years for SRTOY is 44.44%.
- The Selling, General & Administrative Expenses for SRTOY have been equal to 22.20% of Gross Profit Margin.
- The Research & Development expenses have been 4.67% of Revenue.
- The Interest Expense is 37.78% of Operating Income.
- The Net Earning history of SRTOY is 11.16% of Total Revenues.
- Per Share Earnings over the last 19 years have been positive in 16 years.
Sartorius Stedim Biotech SA Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | SRTOY |
| Website: | sartorius.com |
Debt
| Debt-to-Equity Ratio: | 0.69 |
|---|---|
| Current Ratio: | 2.14 |
| Quick Ratio: | 1.08 |
Price-to-Earnings
| Trailing P/E Ratio: | 53.33 |
|---|---|
| Forward P/E Ratio: | 0 |
SRTOY Technical Analysis vs Fundamental Analysis
Sell
48
Sartorius Stedim Biotech SA (SRTOY)
is a Sell
Is Sartorius Stedim Biotech SA a Buy or a Sell?
-
Sartorius Stedim Biotech SA stock is rated a Sell
The current Sartorius Stedim Biotech SA [SRTOY] share price is $19.40. The Score for SRTOY is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.